Invention Grant
![3,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of protein kinases](/docs/US/2018-10-02/US10087182B2/abs.jpg.600x600.jpg)
- Patent Title: 3,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of protein kinases
-
Application No.: US15454760Application Date: 2017-03-09
-
Publication No.: US10087182B2Publication Date: 2018-10-02
- Inventor: Meyyappan Muthuppalaniappan , Srikant Viswanadha , Govindarajulu Babu , Swaroop K. Vakkalanka
- Applicant: Incozen Therapeutics Pvt. Ltd. , Rhizen Pharmaceuticals SA
- Applicant Address: IN Hyderabad CH La Chaux-de-Fonds
- Assignee: INCOZEN THERAPEUTICS PVT. LTD.,RHIZEN PHARMACEUTICALS SA
- Current Assignee: INCOZEN THERAPEUTICS PVT. LTD.,RHIZEN PHARMACEUTICALS SA
- Current Assignee Address: IN Hyderabad CH La Chaux-de-Fonds
- Agency: Blank Rome LLP
- Priority: IN1377/CHE/2010 20100517
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K31/437 ; A61K31/4709 ; A61K31/506 ; A61K31/5377 ; A61K45/06 ; A61K31/496 ; G01N33/50
![3,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of protein kinases](/abs-image/US/2018/10/02/US10087182B2/abs.jpg.150x150.jpg)
Abstract:
The present invention provides, inter alia, compounds of formula I as protein kinase modulators, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of kinase mediated diseases or disorders with them.
Public/Granted literature
Information query
